Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability
- DOI
- 10.1080/19420862.2025.2512211
- Published
- 2025-05-28
- Container
- mAbs
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/19420862.2025.2512211,
title = {Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability},
author = {Paul Considine and Panida Punnabhum and Callum G. Davidson and Georgina B. Armstrong and Michaela Kreiner and Heather J. Bax and Jitesh Chauhan and James Spicer and Debra H. Josephs and Sophia N. Karagiannis and Gavin Halbert and Zahra Rattray},
year = {2025},
journal = {mAbs},
doi = {10.1080/19420862.2025.2512211},
url = {https://doi.org/10.1080/19420862.2025.2512211}
}RIS
TY - JOUR TI - Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability AU - Paul Considine AU - Panida Punnabhum AU - Callum G. Davidson AU - Georgina B. Armstrong AU - Michaela Kreiner AU - Heather J. Bax AU - Jitesh Chauhan AU - James Spicer AU - Debra H. Josephs AU - Sophia N. Karagiannis AU - Gavin Halbert AU - Zahra Rattray PY - 2025 JO - mAbs DO - 10.1080/19420862.2025.2512211 UR - https://doi.org/10.1080/19420862.2025.2512211 ER -
APA
Considine, P., Punnabhum, P., Davidson, C. G., Armstrong, G. B., Kreiner, M., Bax, H. J., Chauhan, J., Spicer, J., Josephs, D. H., Karagiannis, S. N., Halbert, G., & Rattray, Z. (2025). Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability. mAbs. https://doi.org/10.1080/19420862.2025.2512211
Source records
- crossref · retrieved 2026-09-26T23:08:39.118Z